8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Oct 24, 2007)

Filed October 24, 2007For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on October 24, 2007, to announce its financial results for the third quarter and the first nine months of 2007, ending September 30, 2007. This filing primarily serves to incorporate by reference the press release detailing these results, which offers investors insight into the company's operational and financial performance during the period. Investors should refer to the referenced press release (Exhibit 99.1) for specific financial figures, performance metrics, and management commentary. The report indicates that the company has met its reporting obligations for the specified period. The Chief Financial Officer, Robert A. Hagemann, signed off on the filing, underscoring the importance of these results. Investors looking for details on revenue, earnings, margins, and any forward-looking statements or guidance provided by Quest Diagnostics for Q3 2007 and the year-to-date period will need to consult the attached press release.

Key Highlights

  • 1Quest Diagnostics (DGX) filed an 8-K on October 24, 2007, reporting on its financial results.
  • 2The report covers the quarter and nine months ended September 30, 2007.
  • 3The primary purpose of the 8-K is to announce and incorporate by reference a press release detailing these financial results.
  • 4Exhibit 99.1 contains the press release with the specific financial and operational data.
  • 5Investors are directed to the press release for detailed information on Q3 and year-to-date performance.
  • 6The filing was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and include Quest Diagnostics' financial results for the third quarter and the first nine months of 2007, which ended on September 30, 2007. It does this by incorporating a press release (Exhibit 99.1) into the filing.

Specific financial details, including revenue, earnings, and other performance metrics for the quarter and nine months ended September 30, 2007, can be found in the press release attached as Exhibit 99.1 to this 8-K filing.

This 8-K filing itself does not contain new guidance or outlook. It serves to incorporate by reference a press release. Any forward-looking statements or updated guidance would be presented within that press release (Exhibit 99.1).

Robert A. Hagemann is the Senior Vice President and Chief Financial Officer of Quest Diagnostics. His signature on the 8-K filing indicates that the company's management has reviewed and authorized the release of the reported financial information, signifying its official submission to the SEC.